Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression
- PMID: 7791758
- PMCID: PMC230588
- DOI: 10.1128/MCB.15.7.3516
Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression
Abstract
We have investigated the regulation of the insulin-like growth factor I receptor (IGF-I-R) gene promoter by the Wilms' tumor suppressor WT1 in intact cells. The levels of endogenous IGF-I-R mRNA and the activity of IGF-I-R gene promoter fragments in luciferase reporter constructs were found to be significantly higher in G401 cells (a Wilms' tumor-derived cell line lacking detectable WT1 mRNA) than in 293 cells (a human embryonic kidney cell line which expresses significant levels of WT1 mRNA). To study whether WT1 could suppress the expression of the endogenous IGF-I-R gene, WT1-negative G401 cells were stably transfected with a WT1 expression vector. Expression of WT1 mRNA in G401 cells resulted in a significant decrease in the rate of cellular proliferation, which was associated with a reduction in the levels of IGF-I-R mRNA, promoter activity, and ligand binding and with a reduction in IGF-I-stimulated cellular proliferation, thymidine incorporation, and anchorage-independent growth. These data suggest that a major aspect of the action of the WT1 tumor suppressor is the repression of IGF-I-R gene expression.
Similar articles
-
Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.J Mol Neurosci. 1996 Summer;7(2):111-23. doi: 10.1007/BF02736791. J Mol Neurosci. 1996. PMID: 8873895
-
Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.Endocrinology. 2001 Jan;142(1):21-7. doi: 10.1210/endo.142.1.7890. Endocrinology. 2001. PMID: 11145562
-
Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.J Biol Chem. 1994 Apr 29;269(17):12577-82. J Biol Chem. 1994. PMID: 8175666
-
Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression.Endocr J. 1996 Oct;43 Suppl:S49-55. doi: 10.1507/endocrj.43.suppl_s49. Endocr J. 1996. PMID: 9076342 Review.
-
The Wilms' tumor suppressor WT1: approaches to gene function.Kidney Int. 1998 Jun;53(6):1512-8. doi: 10.1046/j.1523-1755.1998.00935.x. Kidney Int. 1998. PMID: 9607183 Review.
Cited by
-
Mechanisms by which IGF-I may promote cancer.Cancer Biol Ther. 2003 Nov-Dec;2(6):630-5. Cancer Biol Ther. 2003. PMID: 14688466 Free PMC article. Review.
-
In silico regulatory analysis for exploring human disease progression.Biol Direct. 2008 Jun 18;3:24. doi: 10.1186/1745-6150-3-24. Biol Direct. 2008. PMID: 18564415 Free PMC article.
-
Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.Br J Cancer. 1998;77(2):253-9. doi: 10.1038/bjc.1998.41. Br J Cancer. 1998. PMID: 9460996 Free PMC article.
-
Targeting the insulin growth factor receptor 1.Hematol Oncol Clin North Am. 2012 Jun;26(3):527-42, vii-viii. doi: 10.1016/j.hoc.2012.01.004. Epub 2012 Feb 28. Hematol Oncol Clin North Am. 2012. PMID: 22520978 Free PMC article. Review.
-
Cancer.Adv Exp Med Biol. 2005;567:305-39. doi: 10.1007/0-387-26274-1_13. Adv Exp Med Biol. 2005. PMID: 16372400 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical